StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.55+0.18 (+4.12%)

Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –

Alvotech total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Alvotech's total debt was $1.31B at Jun 30, 2026. For fiscal 2025 it was $1.30B, up 21.6% from the year before. The highest annual figure on record is $1.30B in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.30B+21.6%
FY2024Dec 31, 2024$1.07B+11.3%
FY2023Dec 31, 2023$960.16M+22.4%
FY2022Dec 31, 2022$784.49M+95.7%
FY2021Dec 31, 2021$400.91M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.31B+23.7%
Q4 FY2025Dec 31, 2025$1.30B+35.3%
Q2 FY2025Jun 30, 2025$1.12B+42.2%
Q4 FY2024Dec 31, 2024$1.07B+36.2%
Q2 FY2024Jun 30, 2024$1.06B+163.4%
Q4 FY2023Dec 31, 2023$960.16M–
Q2 FY2023Jun 30, 2023$786.18M–
Q4 FY2022Dec 31, 2022$784.49M–
Q4 FY2021Dec 31, 2021$400.91M–

More Alvotech figures

See a number that looks wrong?